Zoetis Inc. $ZTS Shares Sold by OLD National Bancorp IN

Key Points

• OLD National Bancorp IN cut its stake in Zoetis by 83.4% in Q4, selling 29,994 shares and leaving 5,978 shares valued at about $752,000.
• Zoetis topped Q results with $1.48 EPS (vs. $1.40 est.) and $2.39B revenue, set FY2026 guidance of $7.00–$7.10 EPS, while analysts' consensus is a Hold with a $152.25 price target (7 buys, 7 holds, 1 sell).

OLD National Bancorp IN cut its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 83.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,978 shares of the company's stock after selling 29,994 shares during the period. OLD National Bancorp IN's holdings in Zoetis were worth $752,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of ZTS. Halbert Hargrove Global Advisors LLC lifted its stake in Zoetis by 496.6% during the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company's stock valued at $25,000 after acquiring an additional 144 shares during the period. Global Wealth Strategies & Associates acquired a new stake in Zoetis during the 4th quarter valued at approximately $25,000. Lodestone Wealth Management LLC acquired a new stake in Zoetis during the 4th quarter valued at approximately $30,000. KERR FINANCIAL PLANNING Corp acquired a new stake in Zoetis during the 3rd quarter valued at approximately $31,000. Finally, Holos Integrated Wealth LLC acquired a new stake in Zoetis during the 4th quarter valued at approximately $32,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ZTS shares. UBS Group set a $136.00 target price on shares of Zoetis in a research note on Thursday, January 29th. Citigroup started coverage on shares of Zoetis in a research note on Wednesday, April 15th. They issued a "buy" rating and a $145.00 target price for the company. William Blair reiterated an "outperform" rating on shares of Zoetis in a research note on Monday, March 2nd. Weiss Ratings cut shares of Zoetis from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Friday, March 27th. Finally, BTIG Research reiterated a "buy" rating and issued a $160.00 target price on shares of Zoetis in a research note on Thursday, February 26th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $152.25.

Zoetis Stock Performance

ZTS opened at $116.92 on Friday. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. The firm has a fifty day moving average price of $120.83 and a 200 day moving average price of $125.53. Zoetis Inc. has a 1 year low of $113.29 and a 1 year high of $172.23. The stock has a market cap of $49.18 billion, a P/E ratio of 19.42, a P/E/G ratio of 1.77 and a beta of 0.98.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The firm's revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Equities research analysts anticipate that Zoetis Inc. will post 7.02 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis's payout ratio is presently 35.22%.

Zoetis Company Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.